Patent · US Expired

Annelated indolo [3,2,-C]lactams

US5223625A · kind A · utility

42Cited by
5References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 16, 1992
Grant dateJun 29, 1993
Priority date
Expiry dateJul 16, 2012

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to a group of new annelated indolo [3,2-c] lactam derivatives of the formula ##STR1## having an antagonistic activity on 5-HT receptors. The compounds can be used for the treatment of symptoms which are caused by excessive stimulation of said receptors in the gastrointestinal system, the central nervous system, the cardiovascular system, the respiratory system, and for alleviating or preventing withdrawal symptoms which are induced by abuse of drugs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.